490 related articles for article (PubMed ID: 17439986)
1. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.
Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP
Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986
[TBL] [Abstract][Full Text] [Related]
2. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
[TBL] [Abstract][Full Text] [Related]
3. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice.
Yan J; Xu L; Welsh AM; Chen D; Hazel T; Johe K; Koliatsos VE
Stem Cells; 2006 Aug; 24(8):1976-85. PubMed ID: 16644922
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model.
Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis.
Ohta Y; Kamiya T; Nagai M; Nagata T; Morimoto N; Miyazaki K; Murakami T; Kurata T; Takehisa Y; Ikeda Y; Asoh S; Ohta S; Abe K
J Neurosci Res; 2008 Oct; 86(13):3028-37. PubMed ID: 18543336
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and functional heterogeneity of GFAP-expressing cells in vitro: differential expression of LeX/CD15 by GFAP-expressing multipotent neural stem cells and non-neurogenic astrocytes.
Imura T; Nakano I; Kornblum HI; Sofroniew MV
Glia; 2006 Feb; 53(3):277-93. PubMed ID: 16267834
[TBL] [Abstract][Full Text] [Related]
7. Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1.
Corti S; Locatelli F; Papadimitriou D; Donadoni C; Del Bo R; Crimi M; Bordoni A; Fortunato F; Strazzer S; Menozzi G; Salani S; Bresolin N; Comi GP
Hum Mol Genet; 2006 Jan; 15(2):167-87. PubMed ID: 16339214
[TBL] [Abstract][Full Text] [Related]
8. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.
Tanaka K; Okada Y; Kanno T; Otomo A; Yanagisawa Y; Shouguchi-Miyata J; Suga E; Kohiki E; Onoe K; Osuga H; Aoki M; Hadano S; Itoyama Y; Ikeda JE
Exp Neurol; 2008 Jun; 211(2):378-86. PubMed ID: 18423451
[TBL] [Abstract][Full Text] [Related]
9. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice.
Zheng C; Sköld MK; Li J; Nennesmo I; Fadeel B; Henter JI
Biochem Biophys Res Commun; 2007 Nov; 363(4):989-93. PubMed ID: 17923114
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice.
Hwang DH; Lee HJ; Park IH; Seok JI; Kim BG; Joo IS; Kim SU
Gene Ther; 2009 Oct; 16(10):1234-44. PubMed ID: 19626053
[TBL] [Abstract][Full Text] [Related]
11. Effect of p75 neurotrophin receptor antagonist on disease progression in transgenic amyotrophic lateral sclerosis mice.
Turner BJ; Murray SS; Piccenna LG; Lopes EC; Kilpatrick TJ; Cheema SS
J Neurosci Res; 2004 Oct; 78(2):193-9. PubMed ID: 15378612
[TBL] [Abstract][Full Text] [Related]
12. A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium.
Ferrucci M; Spalloni A; Bartalucci A; Cantafora E; Fulceri F; Nutini M; Longone P; Paparelli A; Fornai F
Neurobiol Dis; 2010 Feb; 37(2):370-83. PubMed ID: 19874893
[TBL] [Abstract][Full Text] [Related]
13. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice.
Turner BJ; Rembach A; Spark R; Lopes EC; Cheema SS
J Neurosci Res; 2003 Nov; 74(4):605-13. PubMed ID: 14598305
[TBL] [Abstract][Full Text] [Related]
14. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis.
Schaefer AM; Sanes JR; Lichtman JW
J Comp Neurol; 2005 Sep; 490(3):209-19. PubMed ID: 16082680
[TBL] [Abstract][Full Text] [Related]
15. Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS.
Ezzi SA; Larivière R; Urushitani M; Julien JP
J Neurochem; 2010 Dec; 115(5):1102-11. PubMed ID: 20807312
[TBL] [Abstract][Full Text] [Related]
16. Adult olfactory bulb neural precursor cell grafts provide temporary protection from motor neuron degeneration, improve motor function, and extend survival in amyotrophic lateral sclerosis mice.
Martin LJ; Liu Z
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1002-18. PubMed ID: 17984682
[TBL] [Abstract][Full Text] [Related]
17. Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice.
Rizvanov AA; Guseva DS; Salafutdinov II; Kudryashova NV; Bashirov FV; Kiyasov AP; Yalvaç ME; Gazizov IM; Kaligin MS; Sahin F; Mukhamedyarov MA; Palotás A; Islamov RR
Exp Biol Med (Maywood); 2011 Jan; 236(1):91-8. PubMed ID: 21163822
[TBL] [Abstract][Full Text] [Related]
18. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy.
Rizvanov AA; Kiyasov AP; Gaziziov IM; Yilmaz TS; Kaligin MS; Andreeva DI; Shafigullina AK; Guseva DS; Kiselev SL; Matin K; Palotás A; Islamov RR
Neurochem Int; 2008 Dec; 53(6-8):389-94. PubMed ID: 18948156
[TBL] [Abstract][Full Text] [Related]
19. A novel cell transplantation protocol and its application to an ALS mouse model.
Morita E; Watanabe Y; Ishimoto M; Nakano T; Kitayama M; Yasui K; Fukada Y; Doi K; Karunaratne A; Murrell WG; Sutharsan R; Mackay-Sim A; Hata Y; Nakashima K
Exp Neurol; 2008 Oct; 213(2):431-8. PubMed ID: 18691571
[TBL] [Abstract][Full Text] [Related]
20. Impaired SDF1/CXCR4 signaling in glial progenitors derived from SOD1(G93A) mice.
Luo Y; Xue H; Pardo AC; Mattson MP; Rao MS; Maragakis NJ
J Neurosci Res; 2007 Aug; 85(11):2422-32. PubMed ID: 17567884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
